readthroughSign in
CompanyNVAXNasdaqGaithersburg, MD

Novavax

Novavax develops protein-based nanoparticle vaccines using its Matrix-M adjuvant technology platform.

424B3Nov 12Latest SEC filing
Nov 5Latest story